For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
A new study from University of North Carolina Lineberger Comprehensive Cancer Center researchers reveals important findings about how a common genetic mutation in pancreatic cancer works to drive tumor growth. In the journal Cancer Discovery, researchers led by UNC Lineberger’s Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of a particular mutation … Continue reading Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
Channing Der Speaks at MUSC
Cancer survivors, patients, caregivers, and friends, gathered for an awareness reception at Hollings Cancer Center at the Medical University of South Carolina (MUSC). Dr. Channing Der spoke on the latest developments in pancreatic cancer research and treatments. More on the event at MUSC.
Channing Der Interviewed by Science Magazine
Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine
Congratulations, Clint Stalnecker!
Congratulations to Der Lab member, Clint Stalnecker, for winning first place in an oral research presentation competition at the 44th Annual Postdoc-Faculty Research Day! Read more about the 44th Annual Postdoc Faculty Research Day.
Channing Der Quoted by Bloomberg
Right DirectionThe findings follow data this summer that showed half of those treated with Amgen’s drug at a wide range of doses responded. The latest results more than doubled the number of patients treated with the highest dose and tracked them for three more months. It’s too early to know how long the benefits will last and … Continue reading Channing Der Quoted by Bloomberg
Kirsten Bryant Accepts Pagano Award
September 4, 2019 Congratulations to Kirsten Bryant, Ph.D., for her acceptance of the Joseph S. Pagano Award! This award recognizes outstanding work by the Lineberger’s postdoctoral research associates. We are proud of Kirsten's accomplishments. Read more about Kirsten's award ceremony.
Congratulations, Dr. Irem Dagliyan!
Congratulations to Irem Dagliyan for successfully passing her doctoral defense! Irem presented Low dose vertical inhibition of ERK MAPK cascade for the treatment of KRAS-mutant cancer in 4007 Genetic Medicine Building. Afterword, she celebrated her success with her labmates, friends, and family. We are excited for Irem to begin her new journey as Dr. Irem Dagliyan! … Continue reading Congratulations, Dr. Irem Dagliyan!
Kirsten Bryant to Present at Pagano Award Ceremony
Kirsten Bryant, Ph.D., was one of three to be selected through a competitive process for this honor, which comes with a $2,500 award. The three recipients will be formally recognized in the ceremony and Kirsten will present. The Pagano Awards are named for Joseph Pagano, MD, UNC Lineberger director emeritus and Lineberger Professor of Cancer Research. … Continue reading Kirsten Bryant to Present at Pagano Award Ceremony
Der Lab Blue Ribbon Tour 2019
August 5, 2019 Today, the Der and Cox labs were visited by the Blue Ribbon group of Wilmington, NC. The Blue Ribbon Run raises money for the Julie M. Brown and Christina M. Gianoplus Fund for Colon Cancer Research from Wilmington, NC. Members of the group included Ana Boudreau, event founder, and Sarah Powell, a … Continue reading Der Lab Blue Ribbon Tour 2019
Der Lab 